Ibrutinib is a BTK inhibitor, by the way. It’s used to treat Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, and Waldenström’s Macroglobulinemia. So, it stops the BTK signals, that’s how it works.
And it messes with how cancer cells grow and live on, basically. You get it in 140 mg pills or capsules. Doctors usually suggest taking 420 to 560 mg every day.
And the bottles are sized to hold 90 tabs each.